Company presentations
Allegria Therapeutics
Allegria Therapeutics is a Basel-based biopharma start-up established in 2023 with a highly differentiated portfolio of therapeutic approaches to target mast cells as drivers of allergy and inflammatory disease.
Our first-in-class approaches modulate mast cell activity directly and selectively to attain a combination of better efficacy and safety as compared to approaches being pursued thus far.
Date, time and room information
May 6, 13:30 - 13:45, room Singapore
Category
Emerging biotech company
Title of the presentation
Mastering mast cells to more effectively address mast-cell mediated diseases
Speaker information
| Name | Position | Institution |
|---|---|---|
| Maria van Dongen | CEO & Co-founder |
